New Jersey Implements Strict Regulations on Hemp-Derived Intoxicating Products

The New Jersey Cannabis Regulatory Commission (CRC) has announced the enforcement of stringent regulations governing the sale of intoxicating hemp products. This follows a recent federal court ruling that has affected the law’s full implementation. The law, which was initially passed in September, prohibits the unlicensed sale of hemp-derived intoxicants containing synthetic cannabinoids or THC not sourced from naturally occurring compounds.

Regulation Overview

Effective since October 12, the new regulations classify hemp-derived intoxicants in the same manner as state-licensed marijuana products. The provisions are comprehensive, requiring that these products adhere to established safety, testing, and packaging guidelines. Importantly, these products can only be sold to individuals aged 21 and over.

Penalties for Noncompliance

The new law imposes significant penalties for businesses that fail to comply. First-time offenders may incur fines starting at $100, which can escalate to $10,000 for subsequent offenses. Currently, anyone selling these products without a requisite license faces penalties, although the CRC is expected to finalize its licensing procedures within five months.

Beau Huch, a cannabis and hemp attorney from Porzio Governmental Affairs, emphasized the law’s intent to deter illicit activity, stating that it sends a message to those violating regulations.

Background to Legislation

Signed by Governor Phil Murphy on September 12, this legislation aims to tackle rising concerns regarding the accessibility of intoxicating hemp products, particularly to minors, and the oversight of such products proliferating in convenience stores and retail outlets across several states.

By aligning hemp products with high THC levels to marijuana regulations, the CRC seeks to eliminate unregulated competition and guarantee that intoxicating substances maintain strict safety and labeling standards. The law initially targets synthetic cannabinoids such as delta-8 THC, delta-10 THC, and THC-O, which raise safety concerns and could be harmful to consumers.

Challenges and Legal Background

Despite the CRC’s commitment, enforcement of these regulations faced hurdles due to a lawsuit from hemp businesses arguing that the restrictions presented an undue burden on interstate commerce. In the case of Loki Brands LLC et al. v. Platkin et al., a federal judge upheld certain sections of the law but determined that some provisions could not be enforced due to constitutional issues. Nonetheless, several vital enforcement components of the law remain intact.

As lawmakers draft amendments to address the judge’s concerns, the CRC has signaled its intent to enforce the core provisions while awaiting resolution.

Addressing the Farm Bill Loophole

This regulatory push indicates New Jersey’s awareness of concerns regarding hemp-derived products with psychoactive effects akin to marijuana. The 2018 U.S. Farm Bill legalized industrial hemp but inadvertently opened the door for the production of synthetic THC variants derived from hemp CBD, resulting in a significant regulatory loophole.

In response, many states have introduced similar laws to close this exploit and cleanse the market of such products, often packaged to mimic popular food items appealing to minors. Unlike state-regulated marijuana, which is under stringent safety scrutiny, hemp-derived synthetic cannabinoids had largely evaded regulation.

Sales Stalemated

Until the CRC’s new licensing framework is operational, the sale of intoxicating hemp products is halted. The CRC plans to take action against unlicensed retailers who do not comply with the regulations.

Licensed cannabis operators have generally endorsed the regulatory measures as a necessary step towards creating a level playing field. Those in the legal marijuana sector face steep costs and compliance challenges associated with rigorous regulatory measures, while many producers of hemp-derived intoxicants have previously sidestepped these demands. Voices in the medical and recreational marijuana industry argue that these regulations pivot towards consumer safety and fair competition.

Future Directions

The CRC is dedicated to establishing an all-encompassing framework that ensures the safe distribution of hemp-derived intoxicants. The New Jersey Department of Agriculture (NJDA) will maintain oversight of non-intoxicating hemp products meant for fiber and grain, while the CRC takes charge of intoxicating substances.

As New Jersey forges ahead, its regulatory approach illustrates the evolving landscape within the cannabis industry, balancing public safety, fair competition, and the necessity for regulations governing new intoxicants. This legislation presents a challenging yet enlightening set of requirements for local hemp and cannabis enterprises, paving the way for clearer operational guidelines within the state’s legal landscape.